Drappa Jorn
Insider CIK 1789317 · ALPN Director · VIE Chief Medical Officer · ALMS Chief Medical Officer · VTYX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALMS ALUMIS INC. | S Sale | 2026-08-03 | 2026-08-05 | 2,447 | $26.37 | $64.5K | 56,892 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-08-03 | 2026-08-05 | 2,447 | $26.37 | $64.5K | 56,892 | SEC↗ |
| ALMS ALUMIS INC. | M Exercise deriv | 2026-05-22 | 2026-05-27 | 11,317 | — | $0 | 159,805 | SEC↗ |
| ALMS ALUMIS INC. | M Exercise deriv | 2026-05-22 | 2026-05-27 | 15,535 | — | $0 | 164,465 | SEC↗ |
| ALMS ALUMIS INC. | M Exercise | 2026-05-22 | 2026-05-27 | 11,317 | $8.84 | $100.0K | 43,804 | SEC↗ |
| ALMS ALUMIS INC. | M Exercise | 2026-05-22 | 2026-05-27 | 15,535 | $5.06 | $78.6K | 59,339 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2026-01-26 | 2026-01-28 | 221,450 | — | $0 | 221,450 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-29 | 2025-07-31 | 101,850 | — | $0 | 101,850 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2025-07-29 | 2025-07-31 | 25,450 | — | $0 | 28,450 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-02-18 | 2025-02-20 | 180,000 | — | $0 | 180,000 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 70,802 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 54,545 | — | $0 | 54,545 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 54,545 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 18,652 | — | $0 | 18,652 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 18,652 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 12,834 | — | $0 | 12,834 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 12,834 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 171,122 | — | $0 | 171,122 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 171,122 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 85,561 | — | $0 | 85,561 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 85,561 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 5,347 | — | $0 | 5,347 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 5,347 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 64,171 | — | $0 | 64,171 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 64,171 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 70,802 | — | $0 | 70,802 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-06-27 | 2024-07-01 | 5,347 | — | $0 | 5,347 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 20,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2022-07-18 | 2022-07-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-02-04 | 2022-02-04 | 145,000 | — | $0 | 145,000 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 71,842 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 64,000 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 165,000 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer | 2021-03-13 | 2021-03-15 | 202,661 | $53.00 | $10.74M | 0 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 71,842 | — | $0 | 71,842 | SEC↗ |